GYRE vs SYF · rev $53.5M vs rev $11.19B
Gyre Therapeutics Inc. (GYRE) versus SYF (SYF) — a side-by-side from cached financials, not a winner call.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
SYF (SYF) common stock.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
Latest reported SYF revenue for 2026-06-30 was $11.19B. Net income was $1.69B. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. SYF currently screens at market cap $0.
GYRE currently screens at market cap $589.9M. SYF currently screens at market cap $0.
Not investment advice. Open the GYRE and SYF stock pages for the full models.
Not investment advice.